On the other hand, the rest of the DAAs-treated patients (both compensated cirrhosis and F3 hepatitis) presented with significantly smaller tumours (mean HCC size being 3.5 and 3 cm, respectively) and had lower AFP levels, mostly between 100 and 300 ng/ml-in accordance to their dimensions. This evidence concerns the gene AFP and hepatitis A virus infection.